Growth Metrics

Bio-Rad Laboratories (BIO) Long-Term Deferred Tax (2016 - 2019)

Bio-Rad Laboratories (BIO) has disclosed Long-Term Deferred Tax for 11 consecutive years, with $138.0 million as the latest value for Q4 2019.

  • Quarterly Long-Term Deferred Tax rose 80.87% to $138.0 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $138.0 million through Dec 2019, up 80.87% year-over-year, with the annual reading at $138.0 million for FY2019, 80.87% up from the prior year.
  • Long-Term Deferred Tax for Q4 2019 was $138.0 million at Bio-Rad Laboratories, up from $76.3 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $138.0 million in Q4 2019, with the low at $76.3 million in Q4 2018.
  • Average Long-Term Deferred Tax over 5 years is $102.2 million, with a median of $99.5 million recorded in 2015.
  • The sharpest move saw Long-Term Deferred Tax tumbled 32.77% in 2017, then soared 80.87% in 2019.
  • Over 5 years, Long-Term Deferred Tax stood at $99.5 million in 2015, then rose by 18.39% to $117.8 million in 2016, then crashed by 32.77% to $79.2 million in 2017, then dropped by 3.66% to $76.3 million in 2018, then surged by 80.87% to $138.0 million in 2019.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $138.0 million, $76.3 million, and $79.2 million for Q4 2019, Q4 2018, and Q4 2017 respectively.